A Pilot Study of Oral Vorinostat Plus Oral Eltrombopag Support in Patients With Lymphoma (VEIL)

NCT01500538 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

1

Enrollment

OTHER

Sponsor class

Stopped Poor recruitment rate

Conditions

Follicular Lymphoma
Marginal Zone Lymphoma
Mantle Cell Lymphoma

Interventions

DRUG: Eltrombopag and Vorinostat

Sponsor

Peter MacCallum Cancer Centre, Australia

Collaborators

[object Object]
[object Object]